google-site-verification: googlec7193c3de77668c9.html

Antibody therapy eradicates traces of multiple myeloma in preliminary trial

[
Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine. The findings will be presented Dec. 6, 2025, at the American Society of Hematology (ASH) annual meeting in Orlando.


Source link

Advertisements

See also  Researchers track characteristics of firearm owners receiving mental health treatment

Check Also

Genetic clues help reveal kids' cancer risk

[ Every person is a collection of genetic puzzle pieces. On their own, those pieces …

Cellular ‘energetic switch’ could help separate drug rewards from natural pleasure

[ This work reveals that addictive substances drive aberrant dopamine release by co-opting a specific …

New tool helps researchers spot problematic trials before they distort evidence

[ Problematic studies, including those affected by human error or research misconduct, can distort the …

Leave a Reply

Available for Amazon Prime